AstraZeneca Aktie News

AstraZeneca soundly topped analyst views while Sanofi narrowed its losses. Both stocks surged in early trade.

AstraZeneca PLC (LSE:AZN)'s solid rally following Thursday's first-quarter earnings print has made the pharmaceuticals giant Britain's most valuable company, overtaking oil major Shell. AstraZeneca posted a robust set of financial results that sent its share price over 6% higher, meaning its valuation has increased by a quarter since mid-February.

Britain's leading pharmaceuticals company AstraZeneca hit the mark in today's first-quarter earnings print. Total revenue increased by 19% at constant exchange rates to $12.7 billion (£10.2 billion), driven by an 18% increase in product sales.

AstraZeneca reported quarterly revenue and profit above market estimates on Thursday, buoyed by resilient demand for its oncology and rare blood disorder drugs.

CAMBRIDGE, United Kingdom--(BUSINESS WIRE)--Q1 Earnings Release (25 April 2024).

The Magnificent 7 will be hogging US financial news headlines over the coming weeks. Not to be confused with the Yul Byrnner-starring 60s Western classic, the term refers to the seven premier Big Tech stocks on the Nasdaq 100, namely Alphabet, Amazon, Apple, Meta Platforms, Microsoft, NVIDIA and Tesla.

ANGLE PLC (AIM:AGL, OTCQX:ANPCY) shares jumped 30% following the announcement of a strategic partnership with AstraZeneca PLC (LSE:AZN) that aims to advance cancer drug development by enhancing the former's DNA damage response assay. Specifically, the collaboration will focus on adapting ANGLE's existing Parsortix-based assay for identifying micronuclei in circulating tumour cells (CTCs), a cru...

AstraZeneca: What The Market's Missing